NCI's Robust and Rapid Response to the COVID-19 Pandemic - National Cancer Institute

NCI's Robust and Rapid Response to the COVID-19 Pandemic - National Cancer Institute

Cancer Information Highlights

From the National Cancer Institute

Updating you about cancer causes, prevention, screening, treatment, coping, and more

New from NCI NCI’s Response to the COVID-19 Pandemic   NCI Director Dr. Norman Sharpless describes the institute’s contribution to COVID-19 research. Learn about NCI’s COVID-19 research efforts and the expertise and research capabilities that make NCI uniquely qualified to respond to a viral pandemic. NCI Aims to Boost CAR T-Cell Therapy Clinical Trials   CAR T-cell therapy is a promising area of cancer research, but few labs or hospitals are equipped to produce these tailored treatments. Learn how NCI is working to help produce cell therapies so they can be tested in clinical trials at more hospitals. US Deaths from Melanoma Drop After rising for decades, the number of people in the United States who die each year from melanoma has dropped in recent years. Learn more about this cancer and what has led to the decline in deaths. New Drug Approved for NF1 A recent clinical trial showed that a drug called selumetinib reduced tumor size and pain and improved function in children with neurofibromatosis type 1, or NF1. Learn more about NF1 and the trial that led to the drug's approval. PDQ Updates Vulvar Cancer Treatment We’ve revised our PDQ summary on vulvar cancer with updates to the tests used to diagnose and stage the disease and to the treatments used for different stages.

Also of Interest Resources for Caregivers This page provides information to help you take care of yourself and the person with cancer in your life. Also find links to general information about cancer, the latest cancer research, and clinical trials. Coronavirus: What People with Cancer Should Know Cancer and its treatment may increase your risk of having serious health problems from a coronavirus infection. Visit this page often and stay up to date. Contact Us for Help Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.